Non-Alcoholic Steatohepatitis (NASH) Treatment Market Outlook (2025–2034)

The global Non-Alcoholic Steatohepatitis (NASH) Treatment Market was valued at USD 6.55 billion in 2024 and is projected to grow at a CAGR of 5.7% during the forecast period 2025–2034, reaching approximately USD 10.79 billion by 2034. The market expansion is being driven by ongoing advancements in diagnostic techniques and drug development therapies aimed at effectively managing this progressive liver disease.